ELTX
Elicio Therapeutics, Inc.Company with tickers: ELTX
CIK
1601485
CUSIP
28657F103
Shares Outstanding
19,086,081
Website
https://www.elicio.com
Investor Relations
https://elicio.com/investors/
13F Activity (30d)
3 filings
2 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-15 | — | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 10-K/A | 2026-04-29 | 2025-12-31 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-09-17 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-20 | 2025-05-19 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-09 | — | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-24 | 2025-03-21 | |
| 8-K | 2025-03-05 | — | |
| 8-K | 2025-01-30 | 2025-01-29 | |
| 8-K | 2025-01-23 | — | |
| 8-K | 2025-01-22 | — | |
| 8-K | 2024-12-12 | — | |
| 8-K | 2024-12-03 | — | |
| 8-K | 2024-11-21 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-17 | 2024-10-15 | |
| DEF 14A | 2024-09-27 | 2024-11-07 | |
| 8-K | 2024-08-30 | 2024-08-27 | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-07-01 | 2024-06-28 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 10-K/A | 2024-04-29 | 2023-12-31 | |
| 8-K | 2024-04-05 | — | |
| 8-K | 2024-03-29 | — | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2024-03-18 | — | |
| 8-K | 2024-02-02 | 2024-02-01 | |
| 8-K | 2024-01-17 | — |
Showing 1–50 of 102 filings